Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm's products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA.
Company profile
Ticker
AVDR
Exchange
Website
CEO
Reza Zadno
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12B
Securities registration termination
2 Dec 19
25-NSE
Exchange delisting
21 Nov 19
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Nov 19
8-K
Completion of Acquisition or Disposition of Assets
21 Nov 19
8-K
Departure of Directors or Certain Officers
18 Nov 19
425
Business combination disclosure
18 Nov 19
425
Business combination disclosure
14 Nov 19
8-K
Other Events
8 Nov 19
425
Business combination disclosure
8 Nov 19
425
Business combination disclosure
7 Nov 19
Latest ownership filings
Institutional ownership, Q4 2019
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 60 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Proequities | 0.00 | $0.00 |